Friday, August 18, 2017
Company News: Page (1) of 1 - 05/17/17 Email this story to a friend. email article Print this page (Article printing at page facebook
HAMILTON Benefit Performance at SHN Orpheum Theatre Raises Nearly $1 Million for Damon Runyon Cancer Research Foundation
Funds to Support Breakthrough Cancer Research
(May 17, 2017)

SAN FRANCISCO, May 17, 2017 /PRNewswire/ -- The Damon Runyon Cancer Research Foundation hosted a benefit performance of the Broadway musical HAMILTON on Tuesday, May 16, 2017, at the SHN Orpheum Theatre in San Francisco, raising almost $1 million for innovative cancer research. The event attracted notable attendees including: Steve Chen, co-founder of YouTube; Chamath Palihapitiya of Social Capital LP, who is also a part-owner of the Golden State Warriors NBA team and an original member of the Facebook management team; and Mary and Steve Swig, The Swig Co.

"We are thankful to the HAMILTON cast and crew for putting on such a wonderful show benefitting our organization and the funding we provide for cutting-edge cancer research," said Lorraine W. Egan, President and CEO of Damon Runyon. "The Bay Area is a leading incubator for cancer research at Stanford, UCSF, UC Santa Cruz, and UC Berkeley. We've invested over $60 million in Bay Area cancer research programs at these institutions and are confident that the newly raised funds will help expedite our path to the next breakthroughs in cancer research. We also thank the members of our Bay Area Committee who helped promote the event and raise our profile in the Bay Area." 

The Damon Runyon Cancer Research Foundation has enjoyed a long and successful relationship with Broadway. The Foundation was created in 1946 when Walter Winchell went on air with an appeal for contributions to fight cancer in memory of his friend Damon Runyon, a New York writer whose works inspired the hit musical Guys & Dolls. The Damon Runyon Broadway Tickets service was started in the 1950s and it's been vital to the success of the Foundation ever since.

About the Damon Runyon Cancer Research Foundation
To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today's best young scientists with funding to pursue innovative cancer research. The Foundation has invested over $327 million and funded nearly 3,600 young scientists, including 12 Nobel Prize winners. 100% of all donations to the Foundation are used to support scientific research.

Contact: Mahdiyyah Muhammad
[email protected]

To view the original version on PR Newswire, visit:

SOURCE Damon Runyon Cancer Research Foundation

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:Science, Medical, Biology, Cancer,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • HeadAid Products Soon to be Available on
  • Ascension Teams with Plug and Play Tech Center to Connect with Health and Wellness Startups
  • Global Sleep Apnea Devices Market to Grow at a CAGR of 7.8% by 2024 - Large Scale Benefits of Medical Devices is Driving Demand for Medical Platforms.
  • At 8+% CAGR Lateral Flow Assay Market Potentially Worth $8.24 Billion by 2022 Led by Asia-Pacific Region
  • UNITY Biotechnology Announces Extension of Series B Financing Bringing Total Round to $151 Million

  • argenx to host conference call & webcast to report second quarter business update and half year 2017 financial results on August 24, 2017
  • Three Grant Funding Opportunities for Brain Tumor Research Funding Open Today
  • Kitov Pharmaceuticals Provides Corporate Update and Reports First Half 2017 Financial Results
  • ASPCA and the Petco Foundation Partner to Grant $1.5 Million to Dogs Playing For Life to Expand Life-Saving Playgroups Nationwide
  • United States Pain Management Therapeutics Market, Patients Volume, and 50 Companys Pipeline Analysis (By Product, Indication, Phase of Development)

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines